Levensohn Venture Partners

What is Levensohn Venture Partners?

Levensohn Venture Partners is a San Francisco-based venture capital firm that has been providing funding and strategic support to emerging companies since its establishment in 1996. This investor has a distinct approach towards investment, focusing on various high-potential sectors including digital media, healthcare, biotechnology, software (ranging from web marketplaces to SaaS platforms), IT & telecommunications, media, and hardware manufacturing. The fund is known for its adept evaluation of opportunities and invests with a minimum of approximately $6,299,874 and a maximum investment size of around $26,000,000.

Levensohn Venture Partners places a significant emphasis on good governance and effective leadership in its portfolio companies, underlining the importance of self-awareness, sound judgment, and decisive action in company management. They assert that these qualities are teachable, which indicates a hands-on investment style that seeks to enhance the governance and operational aspects of their investees.

They highlight the potential risks faced by angel investors and caution against being blinded by optimism. Additionally, they emphasize the need for improved communication among board members before, during, and after board meetings.

The content of their website suggests a specific interest in issues like board governance dysfunction and offers insights into why startups and family businesses can substantially benefit from independent board governance.

Through their investment strategy, Levensohn Venture Partners strive to not only finance innovation but also ensure that companies have solid foundations upon which they can grow and succeed. A core theme of their philosophy is the notion that for startups to realize their full potential, there must be effective governance structures in place that promote open communication and informed, timely decision-making.

What they say:

We manage diverse portfolios across these innovative sectors.

What we look for: We invest in biotech and information technology, with a focus on breakthrough technologies.